Related Experiment Video
Updated: Oct 13, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Early experience with the Gore TAG thoracic branch endoprosthesis for treatment of acute aortic pathology
Kathryn DiLosa1, Cara Pozolo1, Thomas Heafner1
1Division of Vascular Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA.
Abstract:
The Gore TAG thoracic branch endoprosthesis (TBE) is the first Food and Drug Administration-approved device for zone 2 thoracic endovascular aortic repair, allowing for graft placement proximal to the left subclavian artery origin and maintaining vessel patency through a side branch. We describe our experience with the Gore TBE device in 20 patients for acute indications, including blunt thoracic aortic injuries, complicated dissections, and ruptured aneurysms. Technical success, with exclusion of pathology and left subclavian patency, was 100% without major complications within 30 days. Our early Gore TBE device experience demonstrates safe use in acute aortic pathology without an increased risk of complications.
Related Concept Videos
Thoracic Aorta
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care

